Approvals/NMPA/Recombinant Human Tumor Necrosis Factor-α ReceptorⅡ:IgG Fc Fusion Protein for Injection

Approved

生物制品

Recombinant Human Tumor Necrosis Factor-α ReceptorⅡ:IgG Fc Fusion Protein for Injection

三生国健药业（上海）股份有限公司🇨🇳 National Medical Products Administration

Approval Id: 7LeaeM2DUyf
Approval Number: 国药准字S20050058
Generic Name: 注射用重组人Ⅱ型肿瘤坏死因子受体-抗体融合蛋白
Generic Name En: Recombinant Human Tumor Necrosis Factor-α ReceptorⅡ:IgG Fc Fusion Protein for Injection
Trade Name: 益赛普
Brand Name: 益赛普
Drug Type: 生物制品
Dosage Form: 注射剂
Strength: 12.5mg/瓶
Reg Date: 2019-12-27
Company Name: 三生国健药业（上海）股份有限公司
Company Address: 中国（上海）自由贸易试验区李冰路399号
Production Company Name: 三生国健药业（上海）股份有限公司
Production Company Address: 中国（上海）自由贸易试验区李冰路399号
Company Detail Path: /organization/sunshine-guojian-pharmaceutical-shanghai-co-ltd-6e768c
Production Company Detail Path: /organization/sunshine-guojian-pharmaceutical-shanghai-co-ltd-6e768c

Approved

Agency

NMPA

Country

🇨🇳

Approval Date

Dec 27, 2019

Approval ID

7LeaeM2DUyf

Type

生物制品